Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Share News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 118.50
Bid: 116.00
Ask: 121.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.31%)
Open: 118.50
High: 118.50
Low: 118.50
Prev. Close: 118.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday tips round-up: Misys, UK Mail, Intercede

Fri, 09th Apr 2010 05:49

Misys is in good health but the Independent says it has had a very good run from these shares and anyone who got in below 129.5p could happily take profits. However, that would miss out on a banking recovery, which will happen before too long, so hold.UK Mail has a low-cost network, growing market share ? and, aside from its push into packets, other initiatives such as retail logistics and "imail" (a hybrid between e-mail and letters) through which it should be able to increase sales. It also has forecast net cash of £15 million, raising the prospect of a rise in its already-generous dividend payout ? which currently provides a 5.1 per cent yield. At 333½p, up 15p, or 14 times earnings, hold on, says the Times.Shares in Intercede fell when the company, which makes software that dovetails with identity card systems, said its pre-exceptional operating profits for the full year would miss market expectations. Time to sell, then? Maybe not. At 10.1 times FinnCap's full-year forecasts, it is not at all pricey so the Independent is happy to keep buying.Yesterday's first-half figures show IBT continues to deliver increases in net asset value (NAV) ? up 8 per cent to 164p in the six months to March 31. Helped by clarity over US healthcare reforms, and a Japanese hostile bid for OSI, one of its holdings, NAV has since risen further ? to 178p.The case from here is that half a dozen of IBT's big American stocks, such as Celgene and Vertex, will report important trial results in 2010. Meanwhile, its unquoted portfolio is now of a sufficient maturity to start providing an exit. Above all, American biotech stocks, at 14 times earnings, remain inexpensive ? even more so given that, at 139¾p, IBT sits at a 22 per cent discount to NAV, and will benefit from sterling weakness. Buy, says the Times.At 150½p, up 2p, Alternative Networks shares have outperformed the FTSE all-share index by 13 per cent over the past three months. However, at nine times FinnCap's current-year forecasts, and providing a dividend yield of 5.7 per cent, they are not stretched. Buy, says the Times.Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.
More News
7 Oct 2014 14:49

Intercede cautions on contract timing issues

AIM software company Intercede warned that first half revenues were lower than last year's but reported strong momentum for its MyID mobile digital identity technology. Revenues in the first half will be around £4m, down from £4.6m last time, with the timing of certain larger deals on the order book

Read more
7 Oct 2014 11:23

UK MIDDAY BRIEFING: Travel, Leisure Sector Hit By Spain Ebola Case

Read more
7 Oct 2014 10:49

UK WINNERS & LOSERS: Travel, Leisure Sector Hit By Spain Ebola Case

Read more
7 Oct 2014 07:12

Intercede Shares Fall As It Expects Full Year Revenue To Decline

Read more
29 Sep 2014 08:45

Intercede Gets US Government Order For MyID Credential Management

Read more
26 Jun 2014 16:06

AstraZeneca CFO adds £868,000-worth of shares

The Chief Financial Officer of drug maker AstraZeneca has shown his faith in the group following a setback on Thursday, which saw an advisory committee to the US Food and Drug Association vote against the accelerated approval of its ovarian cancer treatment. Marc Dunoyer, who joined the company in

Read more
26 Jun 2014 09:31

DIRECTOR DEALINGS: Intercede Chairman Buys 12,025 Shares

Read more
25 Jun 2014 12:44

DIRECTOR DEALINGS: Intercede Chairman And Chief Executive Buys

Read more
5 Jun 2014 16:04

Intercede beats forecast and eyes "explosive growth"

Identity cards group Intercede has broken back into the black, with revenues rising even higher than a recent trading update had suggested. The company upped investment in infrastructure, technology development and sales capacity, and said it intended to continue to pursue a "considered" programme

Read more
5 Jun 2014 11:50

Intercede Swings To Pretax Profit On Better Than Expected Sales

LONDON (Alliance News) - Intercede Group PLC Thursday said it swung to a pretax profit in its full-year as it achieved higher than expected sales due to new contract wins during the period. The identity and credential management software company said it swung to a pretax profit of GBP395,00

Read more
3 Apr 2014 11:33

UK MIDDAY BRIEFING: Kingfisher To Acquire French Retailer Mr Bricolage

LONDON (Alliance News) - Europe's largest home improvement retailer Kingfisher saw its shares rise Thursday after saying it is in exclusive negotiations to acquire French home improvement retail chain Mr Bricolage for an overall enterprise vale of around EUR275 million.
<

Read more
3 Apr 2014 10:08

UK WINNERS & LOSERS: Toumaz Leads AIM As Chairman, CEO Buy Shares

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.

-------

FTSE 100 - WINNERS

Tullow Oil, up 4.9%. UBS has upgraded Tullow to Buy from Neutral. Following a sharp fall

Read more
3 Apr 2014 09:10

Intercede Revenues To Be Up 40% On Year, Beating Expectations

LONDON (Alliance News) - Intercede Group PLC Thursday said that revenues for the year ended March 31, will be ahead of expectations and over 40% higher than the previous year, boosted by new contract wins for its MyID identity and credential management technology. Intercede said it had exec

Read more
3 Apr 2014 08:44

Full-year revenue to come in ahead of targets at Intercede

- Sees revenues ahead of forecasts - High levels of demand across all sectors - Confident about future demand AIM-listed security software provider Intercede said it expects revenue for the year ended March 31st to be ahead of forecasts and over 40 per cent higher than last year. The group, which

Read more
7 Feb 2014 09:52

Intercede Teams With Gemalto On Security System For Canada's TELUS

LONDON (Alliance News) - Intercede Group PLC said Friday that it was teaming up with Netherlands-based Gemalto NV to provide a security application for employees of Canadian telecommunications company TELUS Corp. Intercede's MyID system, which integrates Gemalto's Universal Integrated Circu

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.